Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
1 Year
—
-13.82%
Shrank
—
—
Grew
—
1 Year
Score—
Net Growth-13.82%
Net TrendShrank
Net Income Consistency—
Rev Growth—
Rev TrendGrew
Revenue Consistency—
5 Years
—
-48.04%
40%
—
—
20%
—
5 Years
Score—
Net Growth-48.04%
Net Trend40%
Net Income Consistency—
Rev Growth—
Rev Trend20%
Revenue Consistency—
Tenaya Therapeutics Inc fundamental performance
Across Tenaya Therapeutics Inc's full reported history, from 2021 to 2025, revenue held from $ 0.00 to $ 0.00 and net income went from -$ 69M to -$ 90M. Revenue increased in 20% of the years measured; net income in 40%.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 0.76 | — |
1 Year2025-08-12 | $ 0.76 | 0.86% |
5 Years2021-08-12 | $ 22.05 | -96.54% |
All Time2021-07-30 | $ 15.35 | -95.03% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | All Time2021-07-30 |
|---|---|---|---|---|
| Price | $ 0.76 | $ 0.76 | $ 22.05 | $ 15.35 |
| Return | — | 0.86% | -96.54% | -95.03% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 1M | -$ 103M | $ 78M |
| 2025 | $ 0.00 | -$ 90M | $ 100M |
| 2024 | $ 0.00 | -$ 111M | $ 61M |
| 2023 | $ 0.00 | -$ 124M | $ 104M |
| 2022 | $ 0.00 | -$ 123M | $ 186M |
| IPO2021 | $ 0.00 | -$ 69M | $ 251M |
Explore beyond TNYA
You're looking at Tenaya Therapeutics Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
